AlternativeBRAFmutations inBRAFV600E-negative hairy cell leukaemias
Authors:
- 16 January 2014
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 165 (4) , 529-533
Abstract
The BRAF V600E mutation in exon 15 is considered the disease-defining mutation in hairy cell leukaemia (HCL), but single HCL cases lacking this mutation have been described. In 24 HCL, as well as in 194 various mature B- and T-cell neoplasms, we extended the search for BRAF mutations to exon 11. Two V600E-negative HCL contained novel, potentially functionally relevant mutations in exon 11 (F468C and D449E), while one other HCL was BRAF wild-type in exons 2-17. All non-HCL lymphomas lacked BRAF mutations. We therefore suggest screening of BRAF V600E-negative HCL for alternative exon 11 mutations in the diagnostic setting.Keywords
This publication has 14 references indexed in Scilit:
- Investigation of theBRAFV600E Mutation by Pyrosequencing in Lymphoproliferative DisordersAmerican Journal of Clinical Pathology, 2012
- BRAFmutations in chronic lymphocytic leukemiaLeukemia & Lymphoma, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemiaBlood, 2012
- The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasmsBlood, 2012
- High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignanciesBritish Journal of Haematology, 2011
- Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathwaysMolecular Cancer, 2009
- Guilty as chargedCancer Cell, 2004
- Different Effects of Point Mutations within the B-Raf Glycine-Rich Loop in Colorectal Tumors on Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase and Nuclear Factor κB Pathway and Cellular TransformationCancer Research, 2004
- BRAF mutations in non-Hodgkin's lymphomaBritish Journal of Cancer, 2003